251 related articles for article (PubMed ID: 19951647)
1. Is a cystic sebaceous neoplasm always marker for Muir-Torre syndrome?
Arsenovic N; Ramaiya A
Dermatol Online J; 2009 Nov; 15(11):11. PubMed ID: 19951647
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
Abbas O; Mahalingam M
J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
[TBL] [Abstract][Full Text] [Related]
3. Cystic sebaceous tumour with no evidence of Muir-Torre syndrome.
Woo JY; Suhng EA; Choi YW; Choi HY; Byun JY
J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):1038-9. PubMed ID: 25753622
[No Abstract] [Full Text] [Related]
4. Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome.
Harrington CR; Egbert BM; Swetter SM
Dermatol Surg; 2004 May; 30(5):817-9. PubMed ID: 15099333
[TBL] [Abstract][Full Text] [Related]
5. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
[TBL] [Abstract][Full Text] [Related]
6. Sebaceous gland adenoma of the tarsal conjunctiva in a patient with Muir-Torre syndrome.
Font RL; Rishi K
Ophthalmology; 2003 Sep; 110(9):1833-6. PubMed ID: 13129885
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 15 expression in neoplasms with sebaceous differentiation.
Misago N; Narisawa Y
J Cutan Pathol; 2006 Sep; 33(9):634-41. PubMed ID: 16965339
[TBL] [Abstract][Full Text] [Related]
8. Muir-Torre syndrome: case report and review of the literature.
Ang JM; Alai NN; Ritter KR; Machtinger LA
Cutis; 2011 Mar; 87(3):125-8. PubMed ID: 21488569
[TBL] [Abstract][Full Text] [Related]
9. Muir-torre syndrome with intriguing squamous lesions: a case report and review of the literature.
Nishizawa A; Nakanishi Y; Sasajima Y; Yamazaki N; Yamamoto A
Am J Dermatopathol; 2006 Feb; 28(1):56-9. PubMed ID: 16456327
[TBL] [Abstract][Full Text] [Related]
10. Extraocular sebaceous carcinoma: a report of 2 cases.
Cieza-Díaz DE; Cano-Martínez N; Barchino-Ortiz L; Longo-Imedio I
Actas Dermosifiliogr; 2012 Dec; 103(10):919-22. PubMed ID: 23149052
[TBL] [Abstract][Full Text] [Related]
11. Clinical, dermoscopic and reflectance confocal microscopy features of sebaceous neoplasms in Muir-Torre syndrome.
Moscarella E; Argenziano G; Longo C; Cota C; Ardigò M; Stigliano V; Mete LS; Donati P; Piana S; Silipo V; Catricalà C; Albertini G; Zalaudek I
J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):699-705. PubMed ID: 22471909
[TBL] [Abstract][Full Text] [Related]
12. Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.
Shalin SC; Lyle S; Calonje E; Lazar AJ
Histopathology; 2010 Jan; 56(1):133-47. PubMed ID: 20055911
[TBL] [Abstract][Full Text] [Related]
13. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome.
Roberts ME; Riegert-Johnson DL; Thomas BC; Rumilla KM; Thomas CS; Heckman MG; Purcell JU; Hanson NB; Leppig KA; Lim J; Cappel MA
Genet Med; 2014 Sep; 16(9):711-6. PubMed ID: 24603434
[TBL] [Abstract][Full Text] [Related]
14. Deceptively Innocent Façade of Sebaceous Carcinoma in Muir-Torre Syndrome.
Cox SV; Smith J
Dermatol Surg; 2021 Jun; 47(6):828-829. PubMed ID: 33038102
[No Abstract] [Full Text] [Related]
15. [Isolated conjunctival sebaceous adenoma associated with acute endophtalmitis].
Tresserra F; Elizalde J; Ferre B; Gómez-Benlloch A; Martínez-Lanao MÁ; López R
Rev Esp Patol; 2022; 55(1):68-72. PubMed ID: 34980445
[TBL] [Abstract][Full Text] [Related]
16. Review of the current medical literature and assessment of current utilization patterns regarding mismatch repair protein immunohistochemistry in cutaneous Muir-Torre syndrome-associated neoplasms.
Lee JB; Litzner BR; Vidal CI
J Cutan Pathol; 2017 Nov; 44(11):931-937. PubMed ID: 28749576
[TBL] [Abstract][Full Text] [Related]
17. Muir-Torre syndrome.
Cohen PR; Kohn SR; Davis DA; Kurzrock R
Dermatol Clin; 1995 Jan; 13(1):79-89. PubMed ID: 7712655
[TBL] [Abstract][Full Text] [Related]
18. An illustrative case of Muir-Torre syndrome: contribution of immunohistochemical analysis in identifying indicator sebaceous lesions.
Marazza G; Masouyé I; Taylor S; Prins C; Gaudin T; Saurat JH; French LE
Arch Dermatol; 2006 Aug; 142(8):1039-42. PubMed ID: 16924054
[TBL] [Abstract][Full Text] [Related]
19. Sebaceous Carcinoma Arising From Heterotopic Salivary Gland Tissue in a Patient With Muir-Torre Syndrome.
Syder NC; Rabi S; Hu JC
Dermatol Surg; 2021 Dec; 47(12):1659-1660. PubMed ID: 34608093
[No Abstract] [Full Text] [Related]
20. All patients with sebaceous gland neoplasms should be screened for Muir-Torre syndrome.
Ingram JR; Griffiths AP; Roberts DL
Clin Exp Dermatol; 2009 Mar; 34(2):264-6. PubMed ID: 19187311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
